Related Experiment Video
Updated: Feb 19, 2026
08:01
A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
Published on: August 29, 2020
2.7K
Reprogram Murine Epiblast Stem Cells by Epigenetic Inhibitors
Bio-Protocol
|October 31, 2017
Summary
Researchers developed a chemical-only method to reprogram primed mouse Epiblast Stem Cells (EpiSCs) into a naïve pluripotent state. This process involves MM-401 treatment, which inhibits MLL1/KMT2A histone methylation, advancing regenerative medicine applications.
Area of Science:
- Stem cell biology
- Epigenetics
- Regenerative medicine
Background:
- Naïve pluripotent stem cells are crucial for regenerative medicine and tissue engineering.
- Reprogramming primed Epiblast Stem Cells (EpiSCs) to a naïve state is challenging but highly desirable.
- Existing reprogramming methods may involve complex procedures or genetic manipulation.
Purpose of the Study:
- To establish a robust, chemical-only protocol for reprogramming murine EpiSCs to naïve pluripotency.
- To investigate the role of histone methylation in this reprogramming process.
- To provide a simplified method for generating naïve stem cells for research and therapeutic applications.
Main Methods:
- Murine EpiSCs were treated with a chemical cocktail including MM-401.
- MM-401 was used to inhibit the activity of MLL1/KMT2A, a key enzyme in histone H3K4 methylation.
- Standard stem cell culture and characterization techniques were employed to assess pluripotency.
Main Results:
- The chemical-only approach successfully reprogrammed primed EpiSCs to a naïve pluripotent state.
- MM-401 treatment effectively blocked histone H3K4 methylation mediated by MLL1/KMT2A.
- The reprogrammed cells exhibited characteristics of naïve pluripotency.
Conclusions:
- A feasible and robust chemical-only reprogramming method for murine EpiSCs to naïve pluripotency has been developed.
- Inhibition of MLL1/KMT2A-mediated histone methylation is a key mechanism in this reprogramming process.
- This protocol offers a promising avenue for advancing regenerative medicine and tissue engineering.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:32Chromatin Modification in iPS Cells
2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K